» Articles » PMID: 33145464

Proteolysis of Von Willebrand Factor Influences Inflammatory Endothelial Activation and Vascular Compliance in Atherosclerosis

Overview
Date 2020 Nov 4
PMID 33145464
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

This study used in vivo molecular imaging to characterize endotheliall activation attributable to von Willebrand factor (vWF)-mediated platelet adhesion in atherosclerosis. In atherosclerotic mice lacking the low-density lipoprotein receptor on Western diet, the additional genetic deletion of the ADAMTS13, which cleaves endothelial-associated vWF, produced greater aortic molecular imaging signal for not only vWF and platelets, but also for endothelial adhesion molecules VCAM1 and P-selectin, larger plaque size, and lower aortic distensibility. Sustained ADAMTS13 therapy reduced signal for all 4 molecular targets and plaque size. We conclude that excess endothelial-associated vWF contributes to not only platelet adhesion, but also to up-regulation of endothelial cell adhesion molecules.

Citing Articles

Removal of endothelial surface-associated von villebrand factor suppresses accelerate datherosclerosis after myocardial infarction.

Ozawa K, Packwood W, Muller M, Qi Y, Xie A, Varlamov O J Transl Med. 2024; 22(1):412.

PMID: 38693516 PMC: 11062912. DOI: 10.1186/s12967-024-05231-6.


Disturbed flow impairs MerTK-mediated efferocytosis in aortic endothelial cells during atherosclerosis.

Wu J, Liu S, Banerjee O, Shi H, Xue B, Ding Z Theranostics. 2024; 14(6):2427-2441.

PMID: 38646649 PMC: 11024847. DOI: 10.7150/thno.93036.


The Perspectives of Platelet Proteomics in Health and Disease.

Chaudhary P, Upadhayaya S, Kim S, Kim S Biomedicines. 2024; 12(3).

PMID: 38540198 PMC: 10968484. DOI: 10.3390/biomedicines12030585.


Spatial transcriptomics reveals alterations in perivascular macrophage lipid metabolism in the onset of Wooden Breast myopathy in broiler chickens.

Wang Z, Khondowe P, Brannick E, Abasht B Sci Rep. 2024; 14(1):3450.

PMID: 38342952 PMC: 10859375. DOI: 10.1038/s41598-024-53904-5.


.

Ye W, Wang J, Little P, Zou J, Zheng Z, Lu J Acta Pharm Sin B. 2024; 14(1):1-19.

PMID: 38239238 PMC: 10792990. DOI: 10.1016/j.apsb.2023.09.014.


References
1.
Spiel A, Gilbert J, Jilma B . von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes. Circulation. 2008; 117(11):1449-59. DOI: 10.1161/CIRCULATIONAHA.107.722827. View

2.
Flood V, Gill J, Morateck P, Christopherson P, Friedman K, Haberichter S . Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD. Blood. 2010; 117(6):e67-74. PMC: 3056647. DOI: 10.1182/blood-2010-08-299016. View

3.
Bongers T, de Bruijne E, Dippel D, de Jong A, Deckers J, Poldermans D . Lower levels of ADAMTS13 are associated with cardiovascular disease in young patients. Atherosclerosis. 2009; 207(1):250-4. DOI: 10.1016/j.atherosclerosis.2009.04.013. View

4.
Huo Y, Schober A, Forlow S, Smith D, Hyman M, Jung S . Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med. 2002; 9(1):61-7. DOI: 10.1038/nm810. View

5.
Libby P, Ridker P, Hansson G . Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 2009; 54(23):2129-38. PMC: 2834169. DOI: 10.1016/j.jacc.2009.09.009. View